Omics Marker Ltd 12331730 false 2022-12-01 2023-11-30 2023-11-30 The principal activity of the company is data processing, hosting, technical testing and analysis Digita Accounts Production Advanced 6.30.9574.0 true true 12331730 2022-12-01 2023-11-30 12331730 2023-11-30 12331730 bus:OrdinaryShareClass1 2023-11-30 12331730 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 12331730 core:Non-currentFinancialInstruments 2023-11-30 12331730 core:Non-currentFinancialInstruments core:AfterOneYear 2023-11-30 12331730 core:FurnitureFittingsToolsEquipment 2023-11-30 12331730 bus:SmallEntities 2022-12-01 2023-11-30 12331730 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 12331730 bus:FilletedAccounts 2022-12-01 2023-11-30 12331730 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 12331730 bus:RegisteredOffice 2022-12-01 2023-11-30 12331730 bus:Director1 2022-12-01 2023-11-30 12331730 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 12331730 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 12331730 core:FurnitureFittingsToolsEquipment 2022-12-01 2023-11-30 12331730 countries:England 2022-12-01 2023-11-30 12331730 2022-11-30 12331730 core:FurnitureFittingsToolsEquipment 2022-11-30 12331730 2021-12-01 2022-11-30 12331730 2022-11-30 12331730 bus:OrdinaryShareClass1 2022-11-30 12331730 core:CurrentFinancialInstruments core:WithinOneYear 2022-11-30 12331730 core:Non-currentFinancialInstruments 2022-11-30 12331730 core:Non-currentFinancialInstruments core:AfterOneYear 2022-11-30 12331730 core:FurnitureFittingsToolsEquipment 2022-11-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12331730

Omics Marker Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 November 2023

 

Omics Marker Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Omics Marker Ltd

Company Information

Director

Dr Animesh Acharjee

Registered office

18 Centurion Road
Kings Norton
Birmingham
West Midlands
B38 9FH

Accountants

Mr Satraj Suman ACMA
21 Babors Field
Bilston
Wolverhampton
West Midlands
WV14 9XS

 

Omics Marker Ltd

(Registration number: 12331730)
Balance Sheet as at 30 November 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

363

454

Current assets

 

Cash at bank and in hand

 

600

2,916

Creditors: Amounts falling due within one year

5

(1)

(1)

Net current assets

 

599

2,915

Total assets less current liabilities

 

962

3,369

Creditors: Amounts falling due after more than one year

5

(5,244)

(4,019)

Net liabilities

 

(4,282)

(650)

Capital and reserves

 

Called up share capital

6

1

1

Retained earnings

(4,283)

(651)

Shareholders' deficit

 

(4,282)

(650)

For the financial year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 28 August 2024
 

.........................................
Dr Animesh Acharjee
Director

 

Omics Marker Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
18 Centurion Road
Kings Norton
Birmingham
West Midlands
B38 9FH

These financial statements were authorised for issue by the director on 28 August 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

Omics Marker Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 1).

 

Omics Marker Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 December 2022

567

567

At 30 November 2023

567

567

Depreciation

At 1 December 2022

113

113

Charge for the year

91

91

At 30 November 2023

204

204

Carrying amount

At 30 November 2023

363

363

At 30 November 2022

454

454

5

Creditors

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

7

5,244

4,019

6

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary Share of £1 each

1

1

1

1

       

7

Loans and borrowings

Non-current loans and borrowings

2023
£

2022
£

Other borrowings

5,244

4,019

 

Omics Marker Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

8

Related party transactions

 

Omics Marker Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2023

Director's remuneration

The director's remuneration for the year was as follows:

2023
£

2022
£

Remuneration

3,471

-